2004
DOI: 10.2515/therapie:2004109
|View full text |Cite
|
Sign up to set email alerts
|

Attractivité de la France pour la recherche clinique internationale : une étude du Leem dresse un constat peu favorable et suggère des voies d’amélioration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…The most emblematic change took place in March 2007 with the creation of a public interest group (GIP) supported by Interregional Clinical Research Delegations (DIRC) and known as the National Center for Managing Health Product Trials (CeNGEPS) lasting for a period of 4 years. Its objective was to maintain and increase the attractiveness of France for the conduct of clinical research [9,10]. …”
Section: Introductionmentioning
confidence: 99%
“…The most emblematic change took place in March 2007 with the creation of a public interest group (GIP) supported by Interregional Clinical Research Delegations (DIRC) and known as the National Center for Managing Health Product Trials (CeNGEPS) lasting for a period of 4 years. Its objective was to maintain and increase the attractiveness of France for the conduct of clinical research [9,10]. …”
Section: Introductionmentioning
confidence: 99%